The Past, Present and Future of Intestinal In Vitro Cell Systems for Drug Absorption Studies

被引:55
|
作者
Youhanna, Sonia [1 ]
Lauschke, Volker M. [1 ]
机构
[1] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Drug permeability; Bioavailability prediction; Microfluidics; Organoids; Microphysiological models; Preclinical drug development; PRECISION-CUT SLICES; PLASMA-PROTEIN BINDING; UNSTIRRED WATER LAYER; GASTROINTESTINAL-TRACT; CACO-2; CELLS; EX-VIVO; SPECIES-DIFFERENCES; ORAL ABSORPTION; GENE-EXPRESSION; USSING CHAMBER;
D O I
10.1016/j.xphs.2020.07.001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The intestinal epithelium acts as a selective barrier for the absorption of water, nutrients and orally administered drugs. To evaluate the gastrointestinal permeability of a candidate molecule, scientists and drug developers have a multitude of cell culture models at their disposal. Static transwell cultures constitute the most extensively characterized intestinal in vitro system and can accurately categorize molecules into low, intermediate and high permeability compounds. However, they lack key aspects of intestinal physiology, including the cellular complexity of the intestinal epithelium, flow, mechanical strain, or interactions with intestinal mucus and microbes. To emulate these features, a variety of different culture paradigms, including microfluidic chips, organoids and intestinal slice cultures have been developed. Here, we provide an updated overview of intestinal in vitro cell culture systems and critically review their suitability for drug absorption studies. The available data show that these advanced culture models offer impressive possibilities for emulating intestinal complexity. However, there is a paucity of systematic absorption studies and benchmarking data and it remains unclear whether the increase in model complexity and costs translates into improved drug permeability predictions. In the absence of such data, conventional static transwell cultures remain the current gold-standard paradigm for drug absorption studies. (C) 2020 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association (R).
引用
收藏
页码:50 / 65
页数:16
相关论文
共 50 条
  • [1] Drug delivery systems: Past, present, and future
    Mainardes, RM
    Silva, LP
    [J]. CURRENT DRUG TARGETS, 2004, 5 (05) : 449 - 455
  • [2] Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics
    Bicker, Joana
    Alves, Gilberto
    Falcao, Amilcar
    Fortuna, Ana
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (10) : 2215 - 2239
  • [3] Past, Present, and Future Drug Delivery Systems for Antiretrovirals
    Kirtane, Ameya R.
    Langer, Robert
    Traverso, Giovanni
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (12) : 3471 - 3482
  • [4] IN-VITRO SYSTEMS FOR STUDYING INTESTINAL DRUG ABSORPTION
    HILLGREN, KM
    KATO, A
    BORCHARDT, RT
    [J]. MEDICINAL RESEARCH REVIEWS, 1995, 15 (02) : 83 - 109
  • [5] Beta decay studies with the total absorption technique:: past, present and future
    Rubio, B
    Gelletly, W
    Nácher, E
    Algora, A
    Taín, JL
    Pérez, A
    Caballero, L
    [J]. JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS, 2005, 31 (10) : S1477 - S1483
  • [6] Drug hypersensitivity: Past, present and future
    Torres, Maria J.
    Dona, Inmaculada
    [J]. ALLERGY, 2024, 79 (03) : 549 - 551
  • [7] Drug discovery: past, present and future
    Malik, Nafees N.
    [J]. DRUG DISCOVERY TODAY, 2008, 13 (21-22) : 909 - 912
  • [8] DESIGN OF ORAL-DRUG DELIVERY SYSTEMS - PAST, PRESENT AND FUTURE
    HIGUCHI, WI
    HO, NFH
    MERKLE, HP
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1983, 9 (07) : 1227 - 1239
  • [9] Intestinal epithelial pathobiology: past, present and future
    Gewirtz, AT
    Liu, YA
    Sitaraman, SV
    Madara, JL
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2002, 16 (06) : 851 - 867
  • [10] In vitro hematotoxicity testing in drug development:: A review of past, present and future applications
    Rich, IN
    [J]. CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2003, 6 (01) : 100 - 109